إعلان
إعلان
LTRN
Lantern Pharma Inc. Common Stock
3.41
USDبرعاية
-0.04
-1.16%
٠٧ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
3.46
+0.05
+1.44%
تقارير أرباح LTRN
النسبة الإيجابية المفاجئة
LTRN تفوق 16 من 21 آخر التقديرات.
76%
التقرير التالي
بيانات التقرير القادم
٢٥ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.46
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+17.95%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-14.81%
Lantern Pharma Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, LTRN reported earnings of -0.39 USD per share (EPS) for Q3 25, beating the estimate of -0.47 USD, resulting in a 18.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.46 USD, with revenue projected to reach -- USD, implying an زيادة of 17.95% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Lantern Pharma Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lantern Pharma Inc. Common Stock reported EPS of -$0.39, beating estimates by 18.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Lantern Pharma Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.57%, changed from $3.48 before the earnings release to $3.46 the day after.
When is Lantern Pharma Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٥ مارس ٢٠٢٦.
What are the forecasts for Lantern Pharma Inc. Common Stock's next earnings report?
Based on 3
المحللين, Lantern Pharma Inc. Common Stock is expected to report EPS of -$0.46 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان